sirolimus / Generic mfg. |
NCT01049633: B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure |
|
|
| No Longer Available | N/A | | US | Allogeneic Pancreatic Islet Cells, Sirolimus, Basiliximab, Tacrolimus, Antibacterial, Antifungal, and Antiviral Prophylaxis, Trimethoprim/sulfamethoxazole, Septra SS, Clotrimazole, Mycelex Troche, Valganciclovir, Valcyte, Heparin, Anticoagulation and Hematological Agent, Enoxaparin, Lovenox; Anticoagulation and Hematological Agent, Pentoxifylline, Aspirin, ASA | National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Type 1 Diabetes Mellitus | | | | |
| Completed | N/A | 15 | | Rapamycin for external application | Peking Union Medical College Hospital; Peking Union Medical College Hospital, Pfizer Pharmaceuticals Ltd, USA | Vaginal adenosis | | | | |
NCT06409507: Research and Application for New Clinical Diagnosis and Treatment System for HBV Related HCC Liver Transplantation |
|
|
| Completed | N/A | 178 | NA | FKBP12 expression, sirolimus | First People's Hospital of Hangzhou | Hepatocellular Carcinoma, Liver Transplantation, Prognosis | 01/21 | 08/23 | | |
NCT01309022: Immunosuppressive Medications for Participants in ITN005CT (NCT00014911) |
|
|
| No Longer Available | N/A | | US | Sirolimus, Rapamune®, Tacrolimus, Prograf®, Mycophenolate mofetil, MMF, CellCept, Mycophenolic acid, Myfortic® | National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN) | Diabetes Mellitus, Type 1 | | | | |
ChiCTR-OOB-14005683: Metabolic changes in plasma of TSC patients treated with rapamycin using gas chromatography mass spectrometry |
|
|
| Recruiting | N/A | 30 | | mTOR inhibitors | Chinese PLA General Hospital; Chinese PLA General Hospital, Beijing Municipal Science and Technology Committee; The National Basic Research Program of China (973 Program) | Tuberous Sclerosis Complex | | | | |
ChiCTR-IPR-16009305: a Preliminary Study on the Use of Rapamycin in Refractory Graves Hyperthyroidism and Ophthalmopathy |
|
|
| Not yet recruiting | N/A | 171 | | Antithyroid drug monotherapy ;Rapamycin monotherapy ;Rapamycin combined with antithyroid drug treatment | First Affiliated Hospital of Xi'an Jiaotong University; First Affiliated Hospital of Xi'an Jiaotong University, National Scientific Foundation Grand | Retractable Graves Disease and Ophthalmopathy | | | | |
| Not yet recruiting | N/A | 50 | | Use sirolimus for treatment | Children‘s Hospital of Fudan University; Children’s Hospital of Fudan Universiy, Children's Hospital of Fudan University | refractory vascular malformations | | | | |
ChiCTR-OOB-17014129: the imbalance of mTOR mediated autophagy in septic cardiomyopathy and its therapeutic potential |
|
|
| Recruiting | N/A | 120 | | rapamycin ;bafilomycin | Peiking Union Medical College Hospital; PUMCH, Beijing Natural Science Foundation Project | Sepsis induced cardiomyopathy | | | | |
ChiCTR-INR-17012212: Use of sirolimus in patients with primary idiopathic membranous nephropathy: a prospective randomized control trial |
|
|
| Recruiting | N/A | 70 | | Cyclosporine ;cyclosporine combined with sirolimus | Renal Division, Peking University First Hospital; Renal Division, Peking University First Hospital, Huabei Pharmaceutical Company. | idiopathic membranous nephropathy | | | | |
ChiCTR-ONC-17012126: A multicenter, prospective, one-arm clinical study of Sirolimus treats refractory and recurrence primary immune thrombocytopenia |
|
|
| Not yet recruiting | N/A | 103 | | Sirolimus treats refractory or recurrence primary immune thrombocytopenia | Department of Hematology, Xiniao Hospital; Department of Hematology, Xiniao Hospital Department of Hematology, Xiniao Hospital, Clinical Founding of Xinqiao Hospital | refractory or recurrence primary immune thrombocytopenia | | | | |
ChiCTR1900023476: Multicenter, prospective and open clinical study for rapamycin in the treatment of autoimmune hemolytic anemia |
|
|
| Not yet recruiting | N/A | 80 | | glucocorticoid ;glucocorticoid & Ciclosporin ;glucocorticoid & rapamycin ;rapamycin | Tianjin Medical University General Hospital; Tianjin Medical University General Hospital, Clinical Founding | Autoimmune | | | | |
NCT02675153: To Evaluate the Efficacy and Safety of Rapamycin for Crohn's Disease-related Stricture |
|
|
| Recruiting | N/A | 15 | RoW | Rapamycin, Sirolimus | The Second Hospital of Nanjing Medical University | Crohn's Diseases | 10/20 | 10/20 | | |
ChiCTR1900027957: Efficacy and safety of multitarget therapy with cyclophosphamide and sirolimus for lupus nephritis: a single-arm, single-center pilot study |
|
|
| Recruiting | N/A | 20 | | cyclophosphamide and sirolimus | The First Affiliated Hospital of China Medical University; The First Affiliated Hospital of China Medical Universit, None | lupus nephritis | | | | |
NCT06225206: Analysis of Donor-derived Cell Free DNA in Liver Transplant Patients |
|
|
| Recruiting | N/A | 300 | US | donor-derived cell free DNA in liver | Methodist Health System | Liver Transplant Failure | 12/24 | 12/24 | | |
MERIT, ChiCTR2000039839: The role of mTOR gene promoter polymorphism and methylation in the development of incomplete stent endothelialization and restenosis after implantation of sirolimus ramification-coated stent |
|
|
| Recruiting | N/A | 305 | | Rapamycin stent implantation | Zhoupu Hospital of New Pudong District in Shanghai City; Zhoupu Hospital of New Pudong District in Shanghai City, Key discipline group of New Pudong District | Coronary heart disease | | | | |
NCT06196996: Allogeneic Regenerative Islet Transplantation for the Treatment of Brittle Type 1 Diabetes Mellitus |
|
|
| Recruiting | N/A | 18 | RoW | The method of islet transplantation is through percutaneous transhepatic portal vein puncture. | Shanghai Changzheng Hospital | Brittle Type 1 Diabetes Mellitus | 12/25 | 09/26 | | |
ChiCTR2000030370: The efficacy and safety of sirolimus for the treatment of Systemic Sclerosis: a single-arm, single-center pilot study |
|
|
| Recruiting | N/A | 20 | | sirolimus | The First Affiliated Hospital of China Medical University; The First Affiliated Hospital of China Medical University, Self-raised | Systemic Sclerosis | | | | |
ChiCTR2000040947: The safety and effectiveness of rapamycin (sirolimus) in the treatment of Prader-Willi syndrome |
|
|
| Recruiting | N/A | 30 | | rapamycin 1mg qd po | Peking Union Medical College Hospital; Peking Union Medical College Hospital, North China Pharmaceutical Company Ltd. | Prader-Willi syndrome | | | | |
NCT06338306: Tacrolimus and Personalized Therapy to Prevent Acute Rejection Episodes |
|
|
| Recruiting | N/A | 25 | Europe | Tacrolimus(FK506) | Fondazione IRCCS Policlinico San Matteo di Pavia | Heart Transplant Failure | 06/22 | 06/25 | | |
EVALU8, NCT03842813: Safety and Performance Assessment of Drug-Eluting Stent CRE8 in Diabetic Patients |
|
|
| Active, not recruiting | N/A | 1030 | Europe | DES-CRE8 | Alvimedica Medical Technologies France, EVAMED | Diabetes, Coronaropathy | 02/22 | 07/22 | | |
ChiCTR2000032184: Study on the treatment of autism spectrum disorders in children with mTOR inhibitor rapamycin |
|
|
| Not yet recruiting | N/A | 10 | | Rapamycin | The First Medical Center of PLA General Hospital; The First Medical Center of PLA General Hospital, self-finance | Autism Spectrum Disorder | | | | |
NCT00619528: HLA-Identical Sibling Renal Transplant Tolerance |
|
|
| Active, not recruiting | N/A | 230 | US | Infusion of Donor Hematopoietic Stem Cells and Campath-1H | Northwestern University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Immunosuppression, Kidney Transplantation, Graft Rejection | 07/22 | 06/23 | | |
ChiCTR2000035480: The efficacy of sirolimus in different genotypes of low-flow vascular malformations |
|
|
| Not yet recruiting | N/A | 108 | | Oral sirolimus treatment | Ninth People's Hospital, Shanghai JiaoTong University School of Medicine; Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Self-rised | Low-flow vascular malformation | | | | |
ChiCTR2000036637: The efficacy and outcome of sirolimus in different genotypes of low-flow vascular malformations |
|
|
| Not yet recruiting | N/A | 108 | | Nil | Ninth People's Hospital, Shanghai JiaoTong University School of Medicine; The Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shenkang | Low-flow Vascular Malformation | | | | |
ChiCTR2000029921: Sirolimus combined with calcineurin inhibitors for steroid-ineffective/dependent cGVHD: multicenter, single-arm study |
|
|
| Not yet recruiting | N/A | 78 | | given sirolimus capsules combined with ciclosporin(CsA) or tacrolimus(FK506) capsules | The Hematology Department of Xinqiao Hospital, the Second Affiliated Hospital of The Army Medical University; Level of the institution:, Army medical university clinical innovation training program | Steroid- ineffective/dependent cGVHD | | | | |
| Recruiting | N/A | 35 | | use rapamycin | Beijing Jishuitan Hospital; Beijing Jishuitan Hospital, 2016YFC0901500 | PIK3CA related overgrowth syndrome | | | | |
| Completed | N/A | 1300 | Europe | | University Hospital, Geneva, Insel Gruppe AG, University Hospital Bern | Coronary Artery Disease, Acute Coronary Syndrome | 04/23 | 10/23 | | |
NCT06550271: The Bioavailability of Compounded and Generic Rapamycin in Normative Aging Individuals |
|
|
| Completed | N/A | 67 | US | Rapamycin, Sirolimus, Rapamune, Rapacan, Siromus, Raparen, Rapasim, Sirova | AgelessRx | Aging | 12/23 | 12/23 | | |
NCT05294822: Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes |
|
|
| Recruiting | N/A | 20 | RoW | Autologous regenerative islet transplantation for insulin-dependent diabetes mellitus | Shanghai Changzheng Hospital | Diabetes | 06/23 | 12/23 | | |
| Not yet recruiting | N/A | 35 | | rapamycin | The First People’s Hospital of Yichang, Yichang, China; The First People’s Hospital of Yichang, Yichang, China, Self-funded | spinocerebellar ataxia | | | | |
| Recruiting | N/A | 600 | US | Sirolimus, Rapamune, rapamycin, Everolimus, Afinitor | University of Cincinnati, Rare Diseases Clinical Research Network, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), The LAM Foundation | Lymphangioleiomyomatosis | 07/24 | 07/25 | | |
NCT01850108: Non-Myeloablative Conditioning and Bone Marrow Transplantation |
|
|
| Active, not recruiting | N/A | 26 | Europe, US | Thymoglobulin, Fludarabine, Fludara®, Cyclophosphamide (CTX), Cytoxan, Mesna, Sirolimus, rapamycin, Rapamune®, Mycophenolate mofetil (MMF), Bone marrow transplantation, Total body irradiation | Vanderbilt-Ingram Cancer Center | Sickle Cell Disease, Hemoglobinopathies | 11/23 | 12/24 | | |
NCT00001247: Inpatient Evaluation of Adults With Schizophrenia |
|
|
| Recruiting | N/A | 700 | US | Sirolimus | National Institute of Mental Health (NIMH) | Schizophrenia | | | | |
| Active, not recruiting | N/A | 418 | Europe, Canada, US, RoW | SELUTION SLR™ DEB, Control | M.A. Med Alliance S.A., Iqvia Pty Ltd, Cordis Corporation | Coronary Restenosis | 07/25 | 08/29 | | |
NCT06160739: Role of Sirolimus in Treatment of Microcystic , Mixed Lymphatic and Vascular Malformations |
|
|
| Recruiting | N/A | 10 | RoW | Sirolimus 1Mg Oral Tablet | Sohag University | Microcystic Lymphatic Malformation, Combined Vascular Malformation, Vascular Malformations | 09/24 | 09/24 | | |
ChiCTR2000040419: Clinical study of sirolimus combined with chemotherapy in the treatment of recurrent/refractory yolk sac tumor in children |
|
|
| Not yet recruiting | N/A | 32 | | Sirolimus +TIC chemotherapy regimen | Shandong Cancer Hospital and Institute; Shandong Cancer Hospital and Institute, Clinical incubation Program of Shandong Cancer Hospital and Institute | Yolk sac tumor | | | | |
| Recruiting | N/A | 10 | Europe | Exercise, Insulin infusion, Placebo, Rapamycin | University of Copenhagen, Danish Diabetes Academy | Insulin Sensitivity | 06/29 | 06/29 | | |
| Enrolling by invitation | N/A | 100 | US | Rapamycin, Sirolimus, Rapamune | Simmaron Research Inc., Center For Complex Diseases-Seattle, WA, Sierra Internal Medicine, Incline Village, NV, Center for Complex Diseases- Palo Alto, CA, Simmaron Research Inc. R&D Lab, University of Wisconsin, Milwaukee (UWM), Bateman Horne Center, Salt Lake City, UT | Myalgic Encephalomyelitis | 12/25 | 06/26 | | |
ChiCTR1900023865: Kasabach - Merritt phenomenon optimization treatment clinical research program |
|
|
| Recruiting | N/A | 120 | | Corticosteroid ;rapamycin ;hormone in combination with propranolol ;rapamycin in combination with propranolol ;hormone in combination with vincristine ;Rapamycin in combination with hormones | Beijing Children's Hospital Affiliated to Capital Medical University; Anhui Children's Hospital, self-financing | Kaposi form hemangio endothelioma | | | | |
NCT06340373: Clinical and Angiographic Outcomes of Post-drug-coated Balloon Angioplasty in Native Coronary Lesions |
|
|
| Recruiting | N/A | 303 | RoW | DCB Angioplasty | National Institute of Cardiovascular Diseases, Bangladesh | Coronary Artery Disease | 12/24 | 06/25 | | |
NCT05450042: Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation |
|
|
| Recruiting | N/A | 70 | Europe | SELUTION SLR DCB, Paclitaxel DCB | University Hospital, Essen | Peripheral Arterial Disease, Flow-mediated Dilation, Drug Eluting Balloon, Infrainguinal Peripheral Arterial Disease | 04/24 | 04/24 | | |
ChiCTR2000031984: Sirolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex and Epilepsy |
|
|
| Not yet recruiting | N/A | 62 | | Antiepileptic drug + sirolimus ;antiepileptic drugs | West China Hospital, Sichuan University; West China Hospital, Sichuan University, SCI funds for West China Hospital of Sichuan University | Tuberous sclerosis complex; Epilepsy | | | | |
PRE-TREG, NCT04661254: Treg Cell Therapy in Liver and Kidney Transplantation - Preclinical Validation of Batches of Treg Cells Amplified in Vitro |
|
|
| Not yet recruiting | N/A | 4 | Europe | Lymphapheresis | Assistance Publique - Hôpitaux de Paris | Kidney Transplantation, Liver Transplantation | 04/24 | 04/24 | | |
NCT05414292: Impacts of Mechanistic Target of Rapamycin (mTOR) Inhibition on Aged Human Muscle (Rapamune) |
|
|
| Recruiting | N/A | 16 | Europe | Rapamune (sirolimus) 1Mg Tablet, Rapamycin, Sirolimus, Rapamune, Unilateral resistance exercise training, Leg extension, Strength training | University of Nottingham, University of Oxford | Muscle Atrophy, Age-Related Sarcopenia | 05/24 | 05/24 | | |
| Recruiting | N/A | 30 | RoW | ABLUMINUS DES drug eluting stent | Concept Medical Inc. | Peripheral Artery Disease, Arterial Disease of Legs, Atherosclerosis | 06/24 | 12/24 | | |
| Recruiting | N/A | 150 | US | Microsampling | Children's Hospital of Philadelphia, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Immunosuppression | 06/25 | 06/25 | | |
| Recruiting | N/A | 300 | Europe, US, RoW | SELUTION SLR™ 018 DEB, Plain (Uncoated) Balloon Angioplasty (PTA) | MedAlliance, LLC, NAMSA, Cordis Corporation | Peripheral Arterial Disease, Superficial Femoral Artery Stenosis | 12/24 | 12/29 | | |
ChiCTR2100042869: The Efficacy and Safety of Sirolimus Early Conversion Protocol in Liver Transplant Patients with Hepatocellular Carcinoma: a Single-Arm, Multi-Center, Prospective Study |
|
|
| Recruiting | N/A | 397 | | Sirolimus | Shulan (Hangzhou) hospital; Shulan (Hangzhou) hospital, self-raised | Hepatocellular carcinoma | | | | |
ChiCTR2200056185: Efficacy and safety of oral sirolimus in the treatment of pediatric PIK3CA-Related Overgrowth Spectrum(PROS) |
|
|
| Not yet recruiting | N/A | 60 | | oral sirolimus | Beijing Children’s Hospital, Capital Medical University (National Center for Children’s Health, China); Beijing Children’s Hospital, Capital Medical University (National Center for Children’s Health, China), Beijing Natural Science Foundation (No.7222058) | PIK3CA-Related Overgrowth Spectrum(PROS) | | | | |
| Recruiting | N/A | 500 | | rapamycin | Chinese PLA General Hospital; Level of the institution:, Beijing Municipal Science & Technology Committee | tuberous sclerosis complex | | | | |
ChiCTR2300076085: A Study on the Precision Treatment of Congenital Vascular Malformations and the Establishment of PDX Models Based on PI3K-Akt-mTOR Pathway Gene Abnormalities |
|
|
| Not yet recruiting | N/A | 10 | | Gene detection and sirolimus therapy | Fujian Maternal and Child Health Hospital; Fujian Maternal and Child Health Hospital, Fujian Province Science and Technology Innovation Joint Fund Project | Vascular Malformations | | | | |
ChiCTR2400085186: Efficacy and safety of sirolimus in patients with relapsed/refractory idiopathic multicenter Castleman disease |
|
|
| Not yet recruiting | N/A | 30 | | Sirolimus | Peking Union Medical College Hospital; Peking Union Medical College Hospital, the CAMS Fund for Clinical and Translational Medicine Research Project | According to the Expert Consensus on Diagnosis and Treatment of Castleman Disease in China (2021 Edition), patients diagnosed with iMCD who have undergone at least first-line prior treatment meet the criteria for "relapsed" or "refractory" status. | | | | |
NCT05351216: The Effect of Sirolimus on Immunizations During the Treatment of Kaposiform Hemangioendothelioma |
|
|
| Recruiting | N/A | 174 | RoW | | Children's Hospital of Fudan University | Kaposiform Hemangioendothelioma | 03/26 | 03/28 | | |
NCT05613010: Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant |
|
|
| Recruiting | N/A | 50 | US | mHealth Messaging Intervention Group | Johns Hopkins University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Transplant;Failure,Kidney, Transplant; Failure, Liver, Adherence, Medication, Adherence, Patient, Adherence, Treatment | 03/26 | 06/26 | | |
ChiCTR2400082109: A clinical study on the value of moesin in diagnosing and assessing severity of lymphangioleiomyomatosis |
|
|
| Not yet recruiting | N/A | 120 | | sirolimus; nothing; nothing | Zhongshan Hospital, Fudan University; Zhongshan Hospital, Fudan University, Zhongshan Hospital,Fudan University | lymphangioleiomyomatosis | | | | |
| Not yet recruiting | N/A | 20 | NA | Sirolimus, Prednisone | Peking University International Hospital | IgG4-related Disease | 12/26 | 12/28 | | |
ChiCTR2400082459: Effect of m-TOR pathway gene polymorphisms on the efficacy and safety of Sirolimus in liver transplant patients |
|
|
| Not yet recruiting | N/A | 500 | | Non-intervention; Non-intervention | Zhong Shan Hospital, Fudan University; Zhong Shan Hospital, Fudan University, Clinical Research Special Project of Shanghai Municipal Health Commission | Liver transplant | | | | |
| Recruiting | N/A | 50 | | rapamycin | Beijing Children’s Hospital, Capital Medical University; Beijing Children’s Hospital, Capital Medical University, none | Benign peripheral neuroblastic tumors (including GNBi and GN) | | | | |
ChiCTR2400088827: Efficacy and safety of rapamycin combined with roxastat in the treatment of acquired pure red cell aplasia: a prospective, open, randomized, controlled clinical trial |
|
|
| Recruiting | N/A | 180 | | Cyclosporine ± glucocorticoid; Rapamycin and roxastat; Rapamycin and roxastat; Rapamycin | Suzhou Hongci Blood Disease Hospital; Suzhou Hongci Blood Disease Hospital, Self-financing | acquired pure red cell aplasia | | | | |